Expanding Evidence Leads to New Pharmacogenomics Payer Coverage

dc.contributor.authorEmpey, Philip E.
dc.contributor.authorPratt, Victoria M.
dc.contributor.authorHoffman, James M.
dc.contributor.authorCaudle, Kelly E.
dc.contributor.authorKlein, Teri E.
dc.contributor.departmentMedical and Molecular Genetics, School of Medicineen_US
dc.date.accessioned2023-04-05T13:00:55Z
dc.date.available2023-04-05T13:00:55Z
dc.date.issued2021-05
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationEmpey PE, Pratt VM, Hoffman JM, Caudle KE, Klein TE. Expanding evidence leads to new pharmacogenomics payer coverage. Genet Med. 2021;23(5):830-832. doi:10.1038/s41436-021-01117-wen_US
dc.identifier.urihttps://hdl.handle.net/1805/32228
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1038/s41436-021-01117-wen_US
dc.relation.journalGenetics in Medicineen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectPharmacogeneticsen_US
dc.subjectPharmacodynamicsen_US
dc.subjectGenotype-phenotype discoveryen_US
dc.subjectPayer coverageen_US
dc.titleExpanding Evidence Leads to New Pharmacogenomics Payer Coverageen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1710760.pdf
Size:
47.6 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: